NanoVibronix (Nasdaq:NAOV) today announced that it entered into a definitive agreement to sell up to $50 million in stock.

UroMems received FDA investigational device exemption (IDE) approval to begin a first-of-its-kind trial for its smart implant.

Exactech today announced it appointed Dr. Richard J. Friedman as chief medical officer, effective immediately.